Literature DB >> 7515167

Clinical application of cytokines for cancer treatment.

F Takaku1.   

Abstract

As the introduction to a special issue of Oncology on the role of cytokines for cancer treatment, this article summarizes their various current uses. Interferons, interleukin-2 and hematopoietic factors are extensively used for the treatment of hematopoietic as well as nonhematopoietic malignancies, either as the main therapeutic agents or as an adjuvant. Combined usage of several cytokines, or cytokines and chemotherapeutic agents has been tried. Research on gene therapy using cytokines is in progress and expected to become a future modality of cytokine usage in cancer treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515167     DOI: 10.1159/000227326

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  2 in total

1.  Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies.

Authors:  R M Gorczynski; Z Chen; H Zeng; L Gorczynski; E Terzioglu
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

2.  Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.

Authors:  Teresa Rodríguez; Rosa Méndez; Ana Del Campo; Pilar Jiménez; Natalia Aptsiauri; Federico Garrido; Francisco Ruiz-Cabello
Journal:  BMC Cancer       Date:  2007-02-23       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.